Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · June 09, 2023

Long-Term Outcomes of Patients With Pulmonary Oligometastases Treated With Single- vs Multi-Fraction Stereotactic Ablative Body Radiotherapy

Journal of Clinical Oncology


Additional Info

Journal of Clinical Oncology
Long-Term Outcomes of TROG 13.01 SAFRON II Randomized Trial of Single- Versus Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases
J. Clin. Oncol 2023 May 14;[EPub Ahead of Print], S Siva, P Sakyanun, T Mai, W Wong, A Lim, J Ludbrook, C Bettington, A Rezo, D Pryor, N Hardcastle, T Kron, B Higgs, H Le, M Skala, S Gill, T Eade, R Awad, G Sasso, S Vinod, R Montgomery, D Ball, M Bressel

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading